Central India Institute of Medical Sciences Advanced Research Centre
(CIIMS ARC)

Science Save Lives

Collaborating Centre of Excellence

Central India Institute of Medical Sciences Advanced Research Centre
(CIIMS ARC)

Science Save Lives

Collaborating Centre of Excellence

RESEARCH AREA

Neuroinfection , Neuro-metabolic diseases and Neuro-inflammation

Being associated with tertiary care neurology hospital, one of the primary research area of CIIMS ARC is development of cost effective diagnostic panels for Neuroinfections diseases such as Meningitis and Encephalitis infections
  • Bacterial Meningitis

    CIIMS ARC has developed advanced molecular diagnostic approaches for diagnosis of Bacterial meningitis infection. One of the major breakthrough was development of semi nested PCR assay for simultaneous genus specific detection of 8 causative pathogens associated with causing bacterial meningitis at our hospitals. Other developed diagnosis test included duplex PCR for simultaneous identification of TB and other bacteria in meningitis infection.

  • Viral encephalitis

    Similar to bacterial Meningitis, CIIMS ARC through cutting edge research developed advanced molecular diagnostic approaches for detection of viral encephalitis infection which includes Multiplex RT PCR for detection of Neuroviruses (VZV, HSV, CMV, Chandipura, Dengue, JEV, West Nile) along with peptide based immunoassays for rapid and cost effective diagnosis.

  • Evaluating utility of mNGS in Meningoencephalitis infection (ME)

    CIIMS ARC has under Grand challenges funding by Bill Gates foundation & Chan Zuckerberg Initiative is first Research Institute in India working on CSF metagenomics for diagnosis of ME of unknown etiology using mNGS. CIIMS has been working on optimizing NGS based protocol for detection of pathogens through NGS which are often not diagnosed using conventional gold standard approaches. For the same, CIIMS is only Institute in Nagpur having Illumina Benchtop sequencing facility for mNGS.

  • Vector borne infection in CNS infection:

    CIIMS has been regularly screening vector borne infection in CNS. CIIMS ARC was first to demonstrate neurological complication associated with Chikungunya virus during its epidemic peak in Maharashtra in 2008. CIIMS has also identified antigen based biomarkers for Chikungunya viral infection through advanced proteomic tools and developed rapid ELISA based immunoassays (antigen and peptide based) for detection in CSF and blood samples of suspected cases.

  • Stroke and Brain edema

    Apart from neuroinfection, researchers at CIIMS ARC have worked extensively on non-infectious diseases such as stroke and Brain edema. CIIMS has developed in vitro cell line models for stroke for evaluation of neuroprotective efficacy of Ayurvedic drugs. CIIMS ARC also identified various markers such as ITIH4 for early prediction, diagnosis and prognosis of stroke using advanced proteomic tools. The ITIH4 marker was extensively evaluated in longitudinal samples of stroke patients and further developed into peptide based immunoassay for rapid diagnosis & prognosis of stroke. CIIMS ARC also developed and evaluated rat model of stroke for protective efficacy of therapeutic drugs. In addition to stroke, CIIMS ARC has worked extensively on markers of Brian edema such as MMP-9, Aquaporin and also developed animal model for it.

  • Neuro-inflammation

    One of major interest of researcher at CIIMS ARC is to investigate neuro inflammatory cytokines and their role in pathogenies of patients with CNS infections. CIIMS ARC has investigated and shown role of certain anti-inflammatory cytokines like IL-6, IL-10 having protective and prognostic role in CNS infection cases in patients with meningitis and encephalitis infection and even in non-infectious cases like stroke.

Zoonotic infections

Tuberculosis

  • Biomarkers for Tuberculosis

    Investigating novel biomarkers for tuberculosis has been key priority area for CIIMS ARC since its inception. One of the earliest biomarker research carried out by research wing was identification of novel M. tuberculosis Ag85 complex in Cerebrospinal fluid (CSF) of tuberculous meningitis patient which is still used as adjunct diagnostic test for diagnosis & differentiation of Tuberculous meningitis from bacterial meningitis at CIIMS along with other gold standards. Over the past two decades, CIIMS ARC has identified several novel diagnostic markers for TB (under funds provided by ICMR, DBT, DST) which includes host and pathogen markers and established several multiplex panels for rapid diagnosis for pulmonary and extra-pulmonary TB.

  • Epidemiology of TB infection

    CIIMS ARC in collaboration with TB stake holders from time to time has carried out several serological and molecular epidemiologic studies for both Latent and active TB infections in high TB endemic regions of Nagpur and tribal regions of Melghat, Amravati. Through its epidemiology studies, CIIMS ARC has shown high prevalence of latent TB among TB index cases living in high TB endemic areas which subsequently showed servo conversion to active cases. Through Molecular epidemiology studies ARC has shown prevalence of various serovars of TB such as H37Rv, Beijing strain linked with active TB in pulmonary and Brain TB patients.

  • Latent TB

    CIIMS ARC under funding supported by DBT and through in house funds worked extensively on latent TB epidemiology and identification of Latent markers such as Rv2623, Hsp 16 which on extensive evaluation and validation through clinical studies have emerged as promising diagnostic markers for Latent TB having better diagnostic accuracy than commercial Interferon gamma release assays such as QFT and age old TST tests

  • Animal models of TB infection

    CIIMS ARC has developed animal models of TB including aerosol, subcutaneous and intravenous models to study immune response against TB vaccine and biomarkers of protection against TB infection. One of the major work of CIIMS ARC was development of Brain TB model in collaboration with ICMR-JALMA for studies on strain dissemination and evolution of drug efficacy and pharmacokinetic studies in Brain TB infection.

  • Designing and evaluation of TB vaccines

    Apart from epidemiology and biomarkers of TB, researchers at CIIMS ARC worked extensively on boosting efficacy of TB vaccines using its heterologous combination with TB antigens and Its peptides in both animal and cell line models. Scientist from CIIMS also worked on development and evaluation of rBCG vaccines that engages in cytoplasmic immune response mimicking TB infection using animal models.

  • Shortening anti-tuberculosis drug regimen using Bio-enhancers

    CIIMS ARC has been working on use of bioenhancer to increase the bioavailability of TB drugs using cell line and animal models. Under project by Ministry of Ayush, Govt. of India, recently CIIMS has started work on evaluating bio-enhancing efficacy of Cow urine distillate using various models.